Atlas Trials

A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults

Clinical trial NCT07465965 · RECRUITING

Trial details

NCT number
NCT07465965
Sponsor
Shanghai World Leader Pharmaceutical Co., Ltd.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
OverweightObesity
Start date
2026-03-02
Primary completion
2026-08-21
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.